Nephrologist. Thinking in public about kidney disease, delay, and decisions. @nsmcinternship 2024, @isn_india SoMe team
Joined October 2014
- Tweets 655
- Following 724
- Followers 619
- Likes 1,095
82 Photos and videos
Pinned Tweet
28 Apr 2024
Happy to share my *first ever* Visual Abstract!!
All thanks to my amazing mentors at @NSMCInternship!
Reference article: journals.lww.com/jasn/fullte…
2
8
49
5,110
Shreshta Tripathi retweeted
Jun 14
@ASDINNews @AVATAROrg #avatar2026.
👉Networking potential
👉Hands on work shops
👉Meet and greet
👉Interventional Procedures unvieled
Jun 13
Few more days left for early bird registration!! #avatar2026
1
108
CKM Syndrome: Think beyond eGFR.
Stage 0️⃣: No CKM risk factors → Prevention only 🏃🥗
Stage 1️⃣: Excess/dysfunctional adiposity ⚖️
→ Obesity, central adiposity, prediabetes
Check 👉pubmed.ncbi.nlm.nih.gov/4226…
3
2
73
Shreshta Tripathi retweeted
Jun 13
drive.google.com/file/d/1uQT…
submit your abstracts and get your work showcased in India's premier Interventional Nephrology platform #AVATAR2026 @Sandyrvsdav @VinBhargava @arvindcanchi @AVATAROrg @Nair_Sanj @BeheraVineet @InformNephro
6
1
198
Shreshta Tripathi retweeted
🚨🚨ALERT🚨🚨
Important Announcement 📢📣
It's Time to show case your research, Innovation
Submit your abstracts and grab a travel grant and free accomodation for #ISNCON26
Submit your work ASAP
isn-india.org/isn_registrati…
8
7
488
Shreshta Tripathi retweeted
International Faculty Spotlight
#ISNCON26
A pioneering physician-scientist whose work has transformed our understanding of kidney disease & preeclampsia, Dr. Anant Karumanchi @ananthmsn34 will deliver the prestigious K S Chugh Oration✨
📍 Kochi
📅 Dec 17–20, 2026
Register now⏰
7
11
564
Shreshta Tripathi retweeted
Jun 6
#KDIGO update at #ERA26 from @BradRovin
Future of B-cell therapy defined by 3 concepts
🔹Deep B-cell depletion
🔹Immune reset
🔹Disease cure
From CD20 targeting to next-generation therapies, Nephrology is entering an era of "many targets, many therapies"
1
23
42
2,084
Thank you @worldkidneyday for this feature.
A story that shaped my understanding of kidney disease forever.
Honoured to share this story on a global platform.
📢 Our new blog is live!
Dr. Shreshta Tripathi shares the story of a young girl in India living with Alport syndrome, an inherited kidney disorder that progressed to end-stage kidney disease. After years of dialysis, repeated infections, and financial hardship, she finally received a kidney transplant that gave her a chance to rebuild her future. Her story highlights not only the medical challenges of kidney disease, but also the emotional and economic burden carried by entire families.
Read more here 👉 worldkidneyday.org/alport-sy…
#WorldKidneyDay #OurKidneysOurPlanet #KidneyHealthForAll
@ShreshtaT
66
Shreshta Tripathi retweeted
Jun 5
🚨 #TURING at #ERA26
By Dr Lisa Willcocks & @megan_griffith1
TURING tested whether early rituximab could prolong remission and reduce steroid/CNI exposure in adults with de novo or relapsing nephrotic MCD/FSGS.
A much-needed RCT in a field with limited prospective evidence!!
3
18
50
2,374
Shreshta Tripathi retweeted
Jun 5
Wonderful to see our collaborative efforts - released as a publication. Thanks @arvindcanchi @sundaram_r60047 @divyaa24 @MerlPearl @anupamayj @drmjkulkarni @sachinkrao for your kind support. We hope to have learnt enough for making our next initiative a masterpiece.
3
4
9
460
Shreshta Tripathi retweeted
An important milestone, collaborating with @kidney_warriors Foundation led by @Vasuragh in patient-led research. This is important for patient voices to be heard in the field of medicine and nephrology!
link.springer.com/content/pd…
6
7
420
May 29
🩺 Outstanding discussions on MCD, FSGS & Membranous Nephropathy today.
Anti-nephrin antibodies to Rituximab, precision nephrology is evolving rapidly
Grateful to learn from global experts👏
@isn_india @ISGDtweets @kdjhaveri @drshyambansal @koyaljainMD @jradnephro @raja_1980
3
10
745
May 29
🧬 The ROADMAP era in MN is here.
MENTOR, RI-CYCLO, STARMEN & GEMRITUX trials reshaping membranous nephropathy management ⚡
B-cell targeted therapy vs traditional regimens
@isn_india @ISGDtweets @raja_1980 @drshyambansal
4
19
689
May 29
🩺 “Rule of thirds” in Membranous Nephropathy:
1️⃣ Remission
2️⃣ Persistent proteinuria
3️⃣ Progression to kidney failure
Risk stratification remains key in MN management ⚡
@drshyambansal @isn_india @ISGDtweets @ISNeducation @raja_1980
2
25
72
2,286
May 29
🧬 Anti-nephrin antibodies reshaping podocytopathy care.
🔹 Treatment-responsive disease
🔹 Relapses remain common
🔹 Early remission = better prognosis
🔹 RTX emerging in steroid-dependent/frequently relapsing cases ⚡
@jradnephro @ISGDtweets @isn_india @drshyambansal
5
78
May 29
🩺 evolving evidence in adult MCNS/MCD management.
📖JASN study:
🔹 Tacrolimus low-dose steroid: remission rates comparable to high-dose steroids
🔹 with Lower relapse rates
Potential steroid-sparing strategy with clinical relevance. ⚡
@jradnephro @isn_india @ISGDtweets
1
3
143
Shreshta Tripathi retweeted
Over 700 colleagues have already registered! 📌 Don’t miss our free online symposium with @isn_india: Advances in Podocytopathy. Join us live for an essential 2-hour clinical update to advance patient care.
📅 May 29
⏰ 18:30 Delhi / 14:00 London / 09:00 New York
👇 Register:
eu1.hubs.ly/H0vKblH0
1
7
17
1,353
May 29
⚡ Resistant FSGS remains one of the biggest therapeutic challenges in nephrology.
🔹 Steroid resistance seen in 40–60%
🔹 KDIGO 2021 recommends CNIs as next-line therapy
🔹 Rituximab emerging as an important option in selected cases
@isn_india @ISGDtweets @SwatiAr76730089
4
11
449
May 29
🩺 Podocytopathies in focus! ✨
Looking forward to this power-packed webinar by @isn_india & @ISGDtweets led by global experts: @drshyambansal @kdjhaveri @koyaljainMD @jradnephro @raja_1980 @SwatiAr76730089
📅 29 May 2026
⏰ 6:30 PM IST
🔗 youtube.com/live/CiK-UJ0MT6Y…
1
63
Shreshta Tripathi retweeted
High Resolution Ultrasound Appearance of Medullary Sponge Kidney in Primary Distal Renal Tubular Acidosis - in @indianjnephrol
indianjnephrol.org/high-reso…
3
10
421